Giuseppe Ciaramella Beam Therapeutics Inc. (BEAM) insider trading activity

Giuseppe Ciaramella is President of Beam Therapeutics Inc.. Currently has a direct ownership of 109,150 shares of BEAM, which is worth approximately $2.67 Million. The most recent transaction as insider was on Nov 06, 2024, when has been sold 51,110 shares (Common Stock) at a price of $26.36 per share, resulting in proceeds of $1,347,259. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K

35.65% 3M change

21.56% 12M change

Total Value Held $2.67 Million

Giuseppe Ciaramella Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 06 2024	SELL Open market or private sale	$1,347,259 $26.36 p/Share	51,110 Reduced 31.89%	109,150 Common Stock
Oct 14 2024	SELL Open market or private sale	$1,342,659 $26.27 p/Share	51,110 Reduced 24.18%	160,260 Common Stock
Oct 14 2024	BUY Exercise of conversion of derivative security	$168,686 $4.04 p/Share	41,754 Added 16.5%	211,370 Common Stock
Apr 01 2024	SELL Open market or private sale	$145,632 $32.12 p/Share	4,534 Reduced 2.6%	169,616 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	-	35,000 Added 16.73%	174,150 Common Stock
Oct 20 2023	BUY Exercise of conversion of derivative security	$60,903 $0.67 p/Share	90,900 Added 39.51%	139,150 Common Stock
Jul 24 2023	SELL Open market or private sale	$38,604 $32.01 p/Share	1,206 Reduced 2.44%	48,250 Common Stock
Jul 24 2023	BUY Exercise of conversion of derivative security	$8,707 $7.22 p/Share	1,206 Added 2.38%	49,456 Common Stock
Jul 21 2023	SELL Open market or private sale	$4,979,687 $32.06 p/Share	155,324 Reduced 76.3%	48,250 Common Stock
Jul 21 2023	BUY Exercise of conversion of derivative security	$659,070 $7.22 p/Share	91,284 Added 30.96%	203,574 Common Stock
Apr 04 2023	SELL Open market or private sale	$51,023 $29.09 p/Share	1,754 Reduced 1.54%	112,290 Common Stock
Apr 03 2023	SELL Open market or private sale	$58,134 $30.31 p/Share	1,918 Reduced 1.65%	114,044 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	20,000 Added 14.71%	115,962 Common Stock
Jan 03 2023	SELL Open market or private sale	$2,070,715 $38.54 p/Share	53,729 Reduced 35.89%	95,962 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$99,398 $1.85 p/Share	53,729 Added 26.41%	149,691 Common Stock
Dec 30 2022	BUY Exercise of conversion of derivative security	$3,015 $0.67 p/Share	4,500 Added 4.48%	95,962 Common Stock
Dec 12 2022	SELL Open market or private sale	$2,199,256 $43.11 p/Share	51,015 Reduced 35.81%	91,462 Common Stock
Dec 12 2022	BUY Exercise of conversion of derivative security	$65,814 $2.45 p/Share	26,863 Added 15.86%	142,477 Common Stock
Mar 31 2022	SELL Open market or private sale	$109,885 $59.11 p/Share	1,859 Reduced 1.58%	115,614 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	15,000 Added 11.32%	117,473 Common Stock
Dec 29 2021	BUY Exercise of conversion of derivative security	$26,599 $0.67 p/Share	39,700 Added 27.92%	102,473 Common Stock
Dec 22 2021	SELL Open market or private sale	$225,375 $86.45 p/Share	2,607 Reduced 3.99%	62,773 Common Stock
Dec 22 2021	BUY Exercise of conversion of derivative security	$18,823 $7.22 p/Share	2,607 Added 3.83%	65,380 Common Stock
Dec 21 2021	SELL Open market or private sale	$2,154,676 $85.83 p/Share	25,104 Reduced 28.57%	62,773 Common Stock
Dec 21 2021	BUY Exercise of conversion of derivative security	$181,251 $7.22 p/Share	25,104 Added 22.22%	87,877 Common Stock

Giuseppe Ciaramella

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Value

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Beam Therapeutics Inc.

Track Activities on BEAM

Account